INHIBIDORES NO PEPTIDILICOS DE LA UNION A LAS CELULAS DEPENDIENTES DE VLA- 4 UTILES EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS, AUTOINMUNES Y RESPIRATORIAS

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS QUE TIENEN UNA ESTRUCTURA NO PEPTIDILICA Y SON ACTIVOS COMO POTENTES INHIBIDORES DE LA UNION DEL ANTIGENO-4 MUY TARDIO A PROTEINAS COMO LA MOLECULA DE ADHESION CELULAR 1 (VCAM-1), EL DOMINIO HepII/IIICS (regi¢n CS-1) DE FIBRONECTINA Y OSTEOPONTINA. Compo...

Full description

Saved in:
Bibliographic Details
Main Authors ALLEN JACOB DUPLANTIER, LOUIS STANLEY CHUPAK, JHONY JOHN MILICI
Format Patent
LanguageSpanish
Published 11.11.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:LA PRESENTE INVENCION SE REFIERE A COMPUESTOS QUE TIENEN UNA ESTRUCTURA NO PEPTIDILICA Y SON ACTIVOS COMO POTENTES INHIBIDORES DE LA UNION DEL ANTIGENO-4 MUY TARDIO A PROTEINAS COMO LA MOLECULA DE ADHESION CELULAR 1 (VCAM-1), EL DOMINIO HepII/IIICS (regi¢n CS-1) DE FIBRONECTINA Y OSTEOPONTINA. Compounds of Formula (1.0.0):are described wherein A is for example aryl, heteroaryl or heterocyclyl, Y is preferably -C(=O)-; B is independently selected from a group of moieties, the most preferred of which are those of partial Formulas (1.1.2) and (1.1.6):and E is a single bond; oxygen; 1,1-cyclopropyl; C(CH3)2; CF2; or a bridging moiety of partial Formula (1.9.0):where R1a is hydrogen when R1 has the meaning of a mono-valent substituent; and R1a is a single bond when R1 has the meaning of a di-valent substituent. Said compounds are useful in methods of treating or preventing an inflammatory, autoimmune or respiratory diseases by inhibiting cell adhesion and consequent or associated pathogenic processes subsequently mediated by VLA-4.
Bibliography:Application Number: HN191999000099